Gene therapy research in Asia.

Area of Science:

• Biotechnology and Medical Research
• Genetics and Molecular Biology

Background:

• Gene therapy presents a promising frontier for treating previously incurable diseases.
• Significant advancements in gene therapy clinical trials are evident across various severe conditions.
• The Asia region demonstrates remarkable progress in the clinical and industrial application of gene therapy.

Purpose of the Study:

• To review recent developments in gene therapy clinical trials.
• To discuss the future outlook and potential of gene therapy in China and broader Asia.

Main Methods:

• Literature review of recent gene therapy clinical trials.
• Analysis of approved gene therapy products globally and within Asia.
• Synthesis of trends and future prospects for gene therapy in the Asian context.

Main Results:

• Gene therapy has shown success in treating severe diseases like primary immunodeficiencies, leukodystrophies, Leber's congenital amaurosis, hemophilia, and retinal dystrophy.
• Six gene therapy products have been approved worldwide, with two originating from Asia.
• Asia exhibits substantial progress in gene therapy's clinical transformation and industrialization.

Conclusions:

• Gene therapy is a rapidly evolving field with significant therapeutic potential.
• Asia, particularly China, is emerging as a key player in gene therapy innovation and application.
• Continued progress in clinical trials and regulatory approvals points to a bright future for gene therapy in Asia.